Cargando…
Efficacy and the Safety of Granulocyte Colony-Stimulating Factor Treatment in Patients with Muscular Dystrophy: A Non-Randomized Clinical Trial
INTRODUCTION: The current standard treatment for patients with Duchenne muscular dystrophy (DMD) involves corticosteroids. Granulocyte colony-stimulating factor (G-CSF) induces the proliferation of satellite cells and myoblasts and, in turn, muscle regeneration. Beneficial effects of G-CSF were also...
Autores principales: | Sienkiewicz, Dorota, Kułak, Wojciech, Okurowska-Zawada, Bożena, Paszko-Patej, Grażyna, Wojtkowski, Janusz, Sochoń, Karolina, Kalinowska, Anna, Okulczyk, Kamila, Sienkiewicz, Jerzy, McEachern, Edward |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662550/ https://www.ncbi.nlm.nih.gov/pubmed/29123500 http://dx.doi.org/10.3389/fneur.2017.00566 |
Ejemplares similares
-
Biochemical Changes in Blood of Patients with Duchenne Muscular Dystrophy Treated with Granulocyte-Colony Stimulating Factor
por: Sienkiewicz, Dorota, et al.
Publicado: (2019) -
Effect of Periodic Granulocyte Colony-Stimulating Factor Administration on Endothelial Progenitor Cells and Different Monocyte Subsets in Pediatric Patients with Muscular Dystrophies
por: Eljaszewicz, Andrzej, et al.
Publicado: (2016) -
Effectiveness of multiple botulinum toxin sessions and the duration of effects in spasticity therapy in children with cerebral palsy
por: Mirska, Anna, et al.
Publicado: (2018) -
The Effect of Simvastatin on the Dynamics of NF-κB-Regulated Neurodegenerative and Neuroprotective Processes in the Acute Phase of Ischemic Stroke
por: Lietzau, Grazyna, et al.
Publicado: (2023) -
The Importance of Direct Patient Reporting of Adverse Drug Reactions in the Safety Monitoring Process
por: Sienkiewicz, Kamila, et al.
Publicado: (2021)